MUC5AC and bacterial infectious disease: Our infection model findings that metabolism of pulmonary ATP release by apyrase abrogated MUC5AC enhancement of inflammation and secondary bacterial infection identify a potential mechanism through which RV-induced mucin production enhances the severity of COPD exacerbations.